Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA | BSE: 524715

Mid-range Performer

Download real time

1710.40 -17.10 (-0.99%)

1.2M

NSE+BSE Volume

NSE 16 Jul, 2025 12:40 PM (IST)

Analyst Buy

Morgan Stanley initiates coverage on Sun Pharma with an 'Overweight' call; target price of Rs 1,960 See details

Sun Pharmaceutical Industries Ltd. News and Updates

Name: Latest research reports of Sun Pharmaceutical Industries Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Sun Pharmaceutical Industries Ltd.
Rating: 5
Author: Geojit BNP Paribas

Keep track of all breaking news on Sun Pharmaceutical Industries Ltd. from all sources in a single place.

Load latest

Is Sun Pharmaceutical Industries Ltd. worth buying?

1573 Votes:

Buy 75.46%

Sell 15.64%

Hold 8.9%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf